Directors and Officers

 Dr. Jianhua Yang , our founder, has served as the chairman of the board of directors and the chief executive officer of Chemspec since its inception in 2006. Dr. Yang has been chairman and chief executive officer of Shanghai ChemSpec since he founded it in 1996. Dr. Yang has more than 20 years of experience in fluorinated specialty chemicals. Dr. Yang graduated from the Shanghai Institute of Organic Chemistry of the Chinese Academy of Sciences with a Ph.D. in science in 1988. In 1991, Dr. Yang was awarded with the National Natural Science Award (First Class) by the Chinese Academy of Sciences and in 1993, was awarded with the National Natural Science Award (Second Class) by the State Commission on Science and Technology of China.

Mr. Zixin Wang became a member of the board of directors in December 2010. Mr. Wang has served as a Vice President of Chemspec, responsible for finance, administration and human resources, since 2007. From 2006 to 2007, he was the Financial Controller of Chemspec. Prior to joining the company, Mr. Wang served as a project manager of Shanghai Boning Finance Advisory Limited, where he was responsible for advising on offshore initial public offerings of Chinese companies and investment activities in China of foreign companies. Mr. Wang received a master’s degree in Accounting in 2004 and a bachelor’s degree in International Accounting in 2001, both from Shanghai Jiaotong University.

Dr. Kevin Wu became our independent director in June 2010. Dr. Wu helped establish and currently serves as the commercial director of the Emulsion Division of Celanese Company in the Asia Pacific region. Prior to joining Celanese in 2007, Dr. Wu spent 14 years at Rohm and Haas, where he served in various capacities at multiple locations around Asia and North America, including the general manager of the Adhesives and Sealants Division in the Asia Pacific region; the general manager of the Microelectronics Division in Greater China (Mainland China, Taiwan and Hong Kong); and the general manager of Rohm and Haas Electronic Materials Company in Shanghai, China. Dr. Wu obtained a Ph.D. in Chemistry from Columbia University in New York in 1991, an M.B.A. in Marketing from Temple University in Philadelphia in 1999 and a B.S. from Peking University in Beijing, China in 1982.

Dr. Zuowei Xie became our independent director in October 2010. Dr. Xie is currently the Associate Dean of the Faculty of Science and the Chair Professor in the Department of Chemistry at The Chinese University of Hong Kong, where he started his career in 1995. During this period, he received the Croucher Award from the Croucher Foundation (Hong Kong) in 2003, and the State Natural Science Award from the State Commission on Science and Technology of China in 1997 and 2008. Dr. Xie obtained a Ph.D. in 1990 through a collaborative program between Shanghai Institute of Organic Chemistry, Shanghai, China and Technische Universität Berlin, Berlin, Germany. He obtained a B.S. degree in 1983 from Hangzhou University, Hangzhou, Zhejiang Province, China.

Mr. Qian Zhao became our independent director in December 2010. Mr. Zhao is a founding partner of CXC China Sustainable Growth Fund, a private equity fund that makes investments in China-based companies. Mr. Zhao is a lawyer by training and is admitted to practice law in both China and New York. Mr. Zhao co-founded Haiwen & Partners in 1992, a preeminent corporate finance law firm in China and previously worked as an attorney at Sullivan & Cromwell and Skadden, Arps, Slate, Meagher & Flom LLP. Mr. Zhao is currently a director and member of the audit committee of Trina Solar Limited and SouFun Holdings Limited, both of which are NYSE-listed companies, and CXC Capital, Inc., which is the management company of CXC China Sustainable Growth Fund. Mr. Zhao received a J.D. degree from the New York University School of Law in 1998 and an LL.B degree from University of International Business & Economics, Beijing, in 1990.

Dr. Hai Mi became our independent director and chairman of the audit committee in December 2010. Dr. Mi has a broad range of experiences in his professional career in the pharmaceutical and related industries. From 2005 to 2009, Dr. Mi was a Senior Director of Strategic Planning and Vice President of Corporate Communications at WuXi PharmaTech in Shanghai, China. From 2003 to 2004, Dr. Mi served as an independent consultant to Pfizer Inc. in New York, and from 1999 to 2001, he worked as a research scientist at Pfizer in Ann Arbor, Michigan. His other work experience included serving as a general manager, financial advisor and business development consultant for biotech companies. Dr. Mi obtained a Ph.D. in Organic Chemistry from New York University in 1999, an MBA with a concentration in finance and strategic management from The University of Chicago Booth School of Business in 2003 and a B.S. in Material Science from Fudan University in Shanghai in 1989.

For Senior Management Bios please click the link below

Senior Management profiles